About Symetis
Symetis is a company based in Ecublens (Switzerland) founded in 2001 was acquired by Boston Scientific in March 2017.. Symetis has raised $56.66 million across 3 funding rounds from investors including Boston Scientific, Truffle Capital and Endeavour Vision. Symetis has completed 1 acquisition, including Middle Peak Medical. Symetis operates in a competitive market with competitors including Shockwave Medical, Cardiac Dimensions, Venus MedTech, Pi-Cardia and Peijia Medical Technologies, among others.
- Headquarter Ecublens, Switzerland
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$56.66 M (USD)
in 3 rounds
-
Latest Funding Round
$25.8 M (USD), Series C
Oct 07, 2010
-
Investors
Boston Scientific
& 11 more
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
Boston Scientific
(Mar 30, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Symetis
Symetis has successfully raised a total of $56.66M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $25.8 million completed in October 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $25.8M
-
First Round
First Round
(14 Oct 2004)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2010 | Amount | Series C - Symetis | Valuation | Endeavour Vision | |
| Jul, 2009 | Amount | Series B - Symetis | Valuation | Wellington Partners Venture Capital , Renaissance | |
| Oct, 2004 | Amount | Series A - Symetis | Valuation | Truffle Capital , Aravis |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Symetis
Symetis has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, Truffle Capital and Endeavour Vision. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Endeavour Vision is focused on transformative healthcare technology investments.
|
Founded Year | Domain | Location | |
|
Truffle Capital is recognized as a leading European venture capital firm.
|
Founded Year | Domain | Location | |
|
Investments are made in innovative life science companies globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Symetis
Symetis has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Middle Peak Medical. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Mitral valve disease implant technology is developed for cardiac interventions.
|
2011 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Symetis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Symetis Comparisons
Competitors of Symetis
Symetis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Shockwave Medical, Cardiac Dimensions, Venus MedTech, Pi-Cardia and Peijia Medical Technologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cardiovascular balloon dilation catheters with lithotripsy electrodes are developed.
|
|
| domain | founded_year | HQ Location |
Invasive cardiac implants for heart failure treatment are developed.
|
|
| domain | founded_year | HQ Location |
Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures.
|
|
| domain | founded_year | HQ Location |
Non-implant devices for cardiac valve repair are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Medical devices for cardiac and cerebrovascular treatments are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Symetis
Frequently Asked Questions about Symetis
When was Symetis founded?
Symetis was founded in 2001 and raised its 1st funding round 3 years after it was founded.
Where is Symetis located?
Symetis is headquartered in Ecublens, Switzerland. It is registered at Ecublens, Vaud, Switzerland.
Is Symetis a funded company?
Symetis is a funded company, having raised a total of $56.66M across 3 funding rounds to date. The company's 1st funding round was a Series A of $9.6M, raised on Oct 14, 2004.
What does Symetis do?
Symetis was founded in 2001 in Ecublens, Switzerland, within the medical devices sector focused on cardiac therapies. Minimally invasive replacement options for heart valve diseases are developed, including proprietary Acurate TA and Acurate neo systems with delivery mechanisms. These products are marketed across Europe and select international markets. Manufacturing operations are conducted in facilities located in Brazil and Switzerland. A planned initial public offering was suspended in late 2015.
Who are the top competitors of Symetis?
Symetis's top competitors include Shockwave Medical, Cardiac Dimensions and JenaValve Technology.
How many acquisitions has Symetis made?
Symetis has made 1 acquisition, including Middle Peak Medical.
Who are Symetis's investors?
Symetis has 12 investors. Key investors include Boston Scientific, Truffle Capital, Endeavour Vision, Novartis Venture Fund, and Wellington Partners Venture Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.